Asset Management One Co. Ltd. Acquires 66,929 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Asset Management One Co. Ltd. boosted its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report) by 14.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 539,004 shares of the real estate investment trust’s stock after acquiring an additional 66,929 shares during the quarter. Asset Management One Co. Ltd. owned approximately 0.23% of Sabra Health Care REIT worth $10,031,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Family Firm Inc. bought a new position in shares of Sabra Health Care REIT in the second quarter valued at approximately $26,000. GAMMA Investing LLC raised its position in shares of Sabra Health Care REIT by 40.0% in the second quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust’s stock valued at $57,000 after purchasing an additional 1,052 shares during the period. Harbor Capital Advisors Inc. bought a new position in shares of Sabra Health Care REIT in the third quarter valued at approximately $78,000. International Assets Investment Management LLC raised its position in shares of Sabra Health Care REIT by 1,761.0% in the third quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 5,776 shares during the period. Finally, Point72 Hong Kong Ltd bought a new position in shares of Sabra Health Care REIT in the second quarter valued at approximately $117,000. Institutional investors own 99.40% of the company’s stock.

Sabra Health Care REIT Trading Up 4.5 %

Shares of Sabra Health Care REIT stock opened at $19.32 on Friday. The firm has a market capitalization of $4.57 billion, a PE ratio of 47.12, a price-to-earnings-growth ratio of 2.67 and a beta of 1.25. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16. The company’s fifty day moving average price is $18.38 and its two-hundred day moving average price is $16.32. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $19.78.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last posted its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. The firm had revenue of $178.00 million during the quarter, compared to the consensus estimate of $177.19 million. During the same period in the previous year, the company posted $0.34 EPS. On average, analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.21%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT’s payout ratio is 292.69%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on SBRA shares. Scotiabank lifted their price target on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Truist Financial upped their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $18.71.

View Our Latest Report on Sabra Health Care REIT

Sabra Health Care REIT Company Profile

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Featured Articles

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.